| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0304-3835(02)00023-X |
| P698 | PubMed publication ID | 12175530 |
| P2093 | author name string | Roberto Zori | |
| Deborah Marsh | |||
| P2860 | cites work | Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription | Q22001458 |
| The lipid phosphatase activity of PTEN is critical for its tumor supressor function | Q22007981 | ||
| Linkage of ATM to cell cycle regulation by the Chk2 protein kinase | Q22008502 | ||
| Mutations in RECQL4 cause a subset of cases of Rothmund-Thomson syndrome | Q22009558 | ||
| Novel alternatively spliced isoforms of the neurofibromatosis type 2 tumor suppressor are targeted to the nucleus and cytoplasmic granules | Q22010248 | ||
| Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome | Q22011001 | ||
| The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho | Q22254081 | ||
| Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling | Q24290996 | ||
| Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23 | Q24291124 | ||
| Patched1 interacts with cyclin B1 to regulate cell cycle progression | Q24291186 | ||
| Menin interacts directly with the homeobox-containing protein Pem | Q24291549 | ||
| The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation | Q24291618 | ||
| Menin, the product of the MEN1 gene, is a nuclear protein | Q24310070 | ||
| The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment | Q24310211 | ||
| Identification of c-MYC as a target of the APC pathway | Q24310637 | ||
| Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 | Q24313491 | ||
| The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate | Q24317714 | ||
| Mutations of two PMS homologues in hereditary nonpolyposis colon cancer | Q24318484 | ||
| BRCA1 is secreted and exhibits properties of a granin | Q24320316 | ||
| P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 | ||
| Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome | Q24336457 | ||
| Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. | Q24540242 | ||
| The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins | Q24564802 | ||
| Mutator phenotype of Werner syndrome is characterized by extensive deletions | Q24609670 | ||
| Mutation and cancer: statistical study of retinoblastoma | Q24618185 | ||
| Evidence for at least eight Fanconi anemia genes | Q24678164 | ||
| Neurofibromatosis type 2 | Q24681430 | ||
| PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 | ||
| Rad53 FHA domain associated with phosphorylated Rad9 in the DNA damage checkpoint | Q27937738 | ||
| Mutation of a mutL homolog in hereditary colon cancer | Q28114939 | ||
| A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 | Q28115843 | ||
| A serine/threonine kinase gene defective in Peutz-Jeghers syndrome | Q28119198 | ||
| DNA damage-induced activation of p53 by the checkpoint kinase Chk2 | Q28138195 | ||
| The hamartoma-adenoma-carcinoma sequence | Q28139110 | ||
| Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway | Q28141324 | ||
| Familial adenomatous polyposis | Q28144069 | ||
| WT1 proteins: functions in growth and differentiation | Q28191433 | ||
| The von Hippel-Lindau tumor suppressor gene | Q28203455 | ||
| NF1 tumor suppressor gene function: narrowing the GAP | Q28203741 | ||
| The many substrates and functions of ATM | Q28205055 | ||
| LKB1 associates with Brg1 and is necessary for Brg1-induced growth arrest | Q28205561 | ||
| The NF2 interactor, hepatocyte growth factor-regulated tyrosine kinase substrate (HRS), associates with merlin in the "open" conformation and suppresses cell growth and motility | Q28210273 | ||
| Multiple endocrine neoplasia type 1: new clinical and basic findings | Q28211534 | ||
| The gene for multiple endocrine neoplasia type 1: recent findings. | Q33697479 | ||
| Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations | Q33801478 | ||
| Progress in understanding structure-function relationships in respiratory chain complex II. | Q33825154 | ||
| Detecting low penetrance genes in cancer: the way ahead | Q33852849 | ||
| Rothmund-thomson syndrome responsible gene, RECQL4: genomic structure and products | Q33879445 | ||
| The Werner syndrome gene: the molecular basis of RecQ helicase-deficiency diseases | Q33899444 | ||
| Hereditary nonpolyposis colorectal cancer | Q33915595 | ||
| Molecular genetic advances in tuberous sclerosis | Q33921270 | ||
| Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression | Q33944717 | ||
| Clinical manifestations in a cohort of 41 Rothmund-Thomson syndrome patients | Q33953723 | ||
| Accommodating haploinsufficient tumor suppressor genes in Knudson's model | Q33986221 | ||
| Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer. | Q34019577 | ||
| Hereditary breast cancer: a review | Q34019583 | ||
| Hereditary cutaneous melanoma | Q34019605 | ||
| Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes | Q34020502 | ||
| Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. | Q34020644 | ||
| Germline p16 mutations in familial melanoma | Q34059915 | ||
| Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis | Q34080215 | ||
| GDNF - a stranger in the TGF-beta superfamily? | Q34098852 | ||
| Two hits revisited again | Q34131230 | ||
| Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents | Q34146220 | ||
| Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients | Q34166560 | ||
| The retinoblastoma gene: a prototypic and multifunctional tumor suppressor | Q34174294 | ||
| The candidate Wilms' tumour gene is involved in genitourinary development | Q34189819 | ||
| Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? | Q34232464 | ||
| The clinical and diagnostic implications of mosaicism in the neurofibromatoses. | Q34284543 | ||
| The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm | Q34331794 | ||
| Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. | Q34334383 | ||
| Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. | Q34334980 | ||
| Genetics of familial paragangliomas: past, present, and future | Q34369881 | ||
| Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders | Q34386474 | ||
| Fanconi anemia and DNA repair | Q34416703 | ||
| Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest | Q34504424 | ||
| Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus | Q28236741 | ||
| Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping | Q28236877 | ||
| Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1 | Q28243243 | ||
| Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34 | Q28245141 | ||
| Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer | Q28253384 | ||
| The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer | Q28256988 | ||
| Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer | Q28257360 | ||
| Identification and characterization of the tuberous sclerosis gene on chromosome 16 | Q28257738 | ||
| Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase | Q28258611 | ||
| Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma | Q28270834 | ||
| A highly conserved processed PTEN pseudogene is located on chromosome band 9p21 | Q28273178 | ||
| Human homolog of patched, a candidate gene for the basal cell nevus syndrome | Q28281033 | ||
| Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients | Q28300256 | ||
| Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis | Q28300857 | ||
| Association of BRCA1 with Rad51 in mitotic and meiotic cells | Q28302118 | ||
| Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers | Q28306997 | ||
| Positional cloning of the gene for multiple endocrine neoplasia-type 1 | Q28307577 | ||
| VHL c.505 T>C mutation confers a high age related penetrance but no increased overall mortality | Q28345120 | ||
| Differential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesis | Q28354358 | ||
| The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway | Q28361936 | ||
| The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44 | Q28363493 | ||
| Methylation matters | Q28364163 | ||
| Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma | Q28366764 | ||
| Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers | Q28507960 | ||
| Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice | Q28594689 | ||
| Sequential assembly of the nucleotide excision repair factors in vivo | Q28610121 | ||
| WRN mutations in Werner syndrome | Q29395498 | ||
| Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma | Q29614552 | ||
| Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome | Q29615538 | ||
| Identification of the breast cancer susceptibility gene BRCA2 | Q29616290 | ||
| DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 | Q29616726 | ||
| Positional cloning of the Werner's syndrome gene | Q29618393 | ||
| Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms | Q29618586 | ||
| Identification of the von Hippel-Lindau disease tumor suppressor gene | Q29618644 | ||
| Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium | Q29619206 | ||
| The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews | Q29619407 | ||
| Identification and characterization of the familial adenomatous polyposis coli gene | Q29620382 | ||
| Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer | Q48084125 | ||
| Alleles of the APC gene: an attenuated form of familial polyposis | Q48088124 | ||
| A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor | Q48129277 | ||
| The tuberous sclerosis complex: a comprehensive review | Q48354112 | ||
| Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects | Q49075460 | ||
| The expression of RET and its multiple splice forms in developing human kidney. | Q52195115 | ||
| The genetics of melanoma: the UK experience. | Q52866201 | ||
| Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. | Q52887165 | ||
| Different point mutations in the met oncogene elicit distinct biological properties. | Q53413979 | ||
| Allelic imbalance at the LKB1 (STK11) locus in tumours from patients with Peutz-Jeghers' syndrome provides evidence for a hamartoma-(adenoma)-carcinoma sequence. | Q54190005 | ||
| Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. | Q54559294 | ||
| New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. | Q55033068 | ||
| Clinical and Molecular Features of the Carney Complex: Diagnostic Criteria and Recommendations for Patient Evaluation | Q55982494 | ||
| Bloom Syndrome | Q56482234 | ||
| Cancer risk associated with germline DNA mismatch repair gene mutations | Q56813769 | ||
| Sporadic multiple primary melanoma cases:CDKN2Agermline mutations with a founder effect | Q56893701 | ||
| Population-based study of risk of breast cancer in carriers of BRCA2 mutation | Q57250754 | ||
| Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations | Q57250780 | ||
| Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome | Q57266956 | ||
| Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus | Q57269211 | ||
| Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer | Q57568035 | ||
| PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies | Q57591287 | ||
| The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis | Q57591340 | ||
| ONCOGENESIS: Landscaping the Cancer Terrain | Q57636195 | ||
| Localization of the gene for Cowden disease to chromosome 10q22–23 | Q57694734 | ||
| Evidence that WT1 mutations in Denys — Drash syndrome patients may act in a dominant-negative fashion | Q59662118 | ||
| The muir-torre syndrome: a rare variant of hereditary nonpolyposis colorectal cancer associated with hmsh2 mutation | Q60697108 | ||
| Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer | Q61946741 | ||
| Mutations in the APC tumour suppressor gene cause chromosomal instability | Q62024148 | ||
| Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypic characteristics of Wilms' tumour attributable to FWT1 | Q30338002 | ||
| Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12–q21 | Q30338283 | ||
| Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations | Q30495361 | ||
| A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling | Q30495391 | ||
| National Institutes of Health consensus conference: tuberous sclerosis complex | Q30596394 | ||
| Unwinding the molecular basis of the Werner syndrome | Q30667559 | ||
| von Hippel-Lindau disease | Q30726814 | ||
| Cancer risk and the ATM gene: a continuing debate | Q30871076 | ||
| Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. | Q33256073 | ||
| Complications of the naevoid basal cell carcinoma syndrome: results of a population based study | Q33595421 | ||
| Rothmund-Thomson syndrome associated with trisomy 8 mosaicism | Q33597538 | ||
| Gastrointestinal polyposis syndromes | Q33599177 | ||
| Multiple chondromatous hamartomas of the lung: a case report and review of the literature with special reference to Carney syndrome | Q33664439 | ||
| The molecular basis and clinical aspects of Peutz-Jeghers syndrome | Q33667996 | ||
| Instability of lymphocyte chromosomes in a girl with Rothmund-Thomson syndrome | Q33674584 | ||
| A modifying locus for familial adenomatous polyposis may be present on chromosome 1p35-p36 | Q33677191 | ||
| Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma | Q33682786 | ||
| Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome | Q41816411 | ||
| Identification of germline and somatic mutations affecting the retinoblastoma gene | Q41830287 | ||
| Screening SMAD1, SMAD2, SMAD3, and SMAD5 for germline mutations in juvenile polyposis syndrome | Q41983219 | ||
| Cancer-associated mis-sense and deletion mutations impair p16INK4 CDK inhibitory activity | Q42064477 | ||
| Characterization of tumor-associated Chk2 mutations | Q42495187 | ||
| Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations | Q42662265 | ||
| Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2. | Q42803782 | ||
| Familial Wilms tumour resulting from WT1 mutation: intronic polymorphism causing artefactual constitutional homozygosity | Q43075986 | ||
| Hamartin and tuberin expression in human tissues | Q43552410 | ||
| Germline SDHD mutation in familial phaeochromocytoma | Q43588788 | ||
| Novel mutations and the emergence of a common mutation in the SDHD gene causing familial paraganglioma | Q43601273 | ||
| Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. | Q43623240 | ||
| Novel mutations in the SDHD gene in pedigrees with familial carotid body paraganglioma and sensorineural hearing loss | Q43629699 | ||
| Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene | Q43629703 | ||
| The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis | Q44463232 | ||
| Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation | Q45345194 | ||
| Mutations in the SMAD4/DPC4 gene in juvenile polyposis | Q45345229 | ||
| Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas | Q45345804 | ||
| Mutations in SDHC cause autosomal dominant paraganglioma, type 3. | Q47817141 | ||
| PTEN and inherited hamartoma-cancer syndromes | Q47852476 | ||
| NF2 gene in neurofibromatosis type 2 patients. | Q48007953 | ||
| Growth retardation and tumour inhibition by BRCA1. | Q48066075 | ||
| A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening | Q63363987 | ||
| Exclusion of linkage of loci on chromosome 19 with multiple endocrine neoplasia, type 2 | Q69900961 | ||
| Risk estimation and screening in families of patients with medullary thyroid carcinoma | Q69912692 | ||
| Attenuated familial adenomatous polyposis due to a mutation in the 3' part of the APC gene. A clue for understanding the function of the APC protein | Q71131035 | ||
| Rothmund-Thomson syndrome in siblings: evidence for acquired in vivo mosaicism | Q71340549 | ||
| Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours | Q72679743 | ||
| Genetics of Wilms' tumor | Q72898630 | ||
| Neurofibromatosis type 2 attributable to gonosomal mosaicism in a clinically normal mother, and identification of seven novel mutations in the NF2 gene | Q73326054 | ||
| RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma | Q73377853 | ||
| von Hippel-Lindau disease | Q73567751 | ||
| Protein kinase A in Carney complex: a new example of cAMP pathway alteration in endocrine tumors | Q73615090 | ||
| A splicing mutation in RB1 in low penetrance retinoblastoma | Q73814979 | ||
| Is familial hyperparathyroidism a unique disease? | Q74028932 | ||
| CDKN2A mutations in multiple primary melanomas | Q74357667 | ||
| Lethality of multiple endocrine neoplasia type I | Q74580275 | ||
| A novel missense mutation in patients from a retinoblastoma pedigree showing only mild expression of the tumor phenotype | Q74792673 | ||
| Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours | Q77138821 | ||
| The risk of gastrointestinal carcinoma in familial juvenile polyposis | Q77738187 | ||
| Differential expression of p53, p21waf1/cip1 and hdm2 dependent on DNA damage in Bloom's syndrome fibroblasts | Q77787939 | ||
| Frequent 4-bp deletion in exon 9 of the SMAD4/MADH4 gene in familial juvenile polyposis patients | Q77977521 | ||
| Loss of cytoplasmic retention ability of mutant LKB1 found in Peutz-Jeghers syndrome patients | Q78109607 | ||
| Ashkenazi Jewish population frequency of the Bloom syndrome gene 2281 delta 6ins7 mutation | Q78178727 | ||
| Cowden Syndrome | Q85527281 | ||
| Neurofibromatosis 1 | Q95809990 | ||
| Cancer risks in BRCA2 mutation carriers | Q34504452 | ||
| Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. | Q34510622 | ||
| Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex | Q34512350 | ||
| von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. | Q34514928 | ||
| The molecular basis of Turcot's syndrome | Q34662365 | ||
| Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect | Q34722365 | ||
| Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium | Q34724404 | ||
| Bloom's syndrome. XX. The first 100 cancers | Q34738495 | ||
| A clinical overview of WT1 gene mutations | Q34738955 | ||
| The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix | Q34748818 | ||
| The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity | Q35201819 | ||
| Confirmation of a double-hit model for the NF1 gene in benign neurofibromas | Q35249470 | ||
| Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast | Q35788322 | ||
| Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors | Q35810225 | ||
| Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology | Q36108223 | ||
| Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription | Q36370019 | ||
| Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations | Q36550021 | ||
| Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2 | Q36621758 | ||
| Isolation and characterization of a human pseudogene for the regulatory subunit RI alpha of cAMP-dependent protein kinases and its sublocalization on chromosome 1. | Q36779909 | ||
| Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain | Q36818855 | ||
| Wild-type p53 is a cell cycle checkpoint determinant following irradiation | Q37152060 | ||
| Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products | Q37230912 | ||
| Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression | Q37421517 | ||
| Alternative splicing and genomic structure of the Wilms tumor gene WT1 | Q37611742 | ||
| Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry | Q37619481 | ||
| Heterozygous ATM mutations do not contribute to early onset of breast cancer | Q38348222 | ||
| Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory | Q38367968 | ||
| Werner's syndrome: a review of recent research with an analysis of connective tissue metabolism, growth control of cultured cells, and chromosomal aberrations | Q40250901 | ||
| Nucleotide excision repair syndromes: molecular basis and clinical symptoms | Q40522927 | ||
| Genetic events in the development of Wilms' tumor | Q40681250 | ||
| Clinical experience over 48 years with pheochromocytoma | Q40810053 | ||
| Bloom helicase is involved in DNA surveillance in early S phase in vertebrate cells. | Q40811109 | ||
| Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review | Q40901949 | ||
| Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma | Q40978415 | ||
| Restoration of CDKN2A into melanoma cells induces morphologic changes and reduction in growth rate but not anchorage-independent growth reversal | Q41102901 | ||
| Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. | Q41157114 | ||
| Cancers in 44 families with ataxia-telangiectasia | Q41213089 | ||
| The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds | Q41226231 | ||
| Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells | Q41407134 | ||
| Responses to DNA damage and regulation of cell cycle checkpoints by the ATM protein kinase family | Q41441663 | ||
| Genetics of cutaneous melanoma and nevi | Q41467316 | ||
| Hypermutability and mismatch repair deficiency in RER+ tumor cells | Q41508298 | ||
| Hypomethylation of classical satellite DNA and chromosome instability in lymphoblastoid cell lines | Q41544550 | ||
| A long-sought needle in the haystack: the multiple endocrine neoplasia type 1 gene | Q41612073 | ||
| Transcriptional repression mediated by the WT1 Wilms tumor gene product | Q41661461 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 125-164 | |
| P577 | publication date | 2002-07-01 | |
| P1433 | published in | Cancer Letters | Q326372 |
| P1476 | title | Genetic insights into familial cancers-- update and recent discoveries | |
| P478 | volume | 181 |
| Q53997240 | A Computational Model of Oncogenesis using the Systemic Approach |
| Q36068314 | Clinical and molecular genetics of primary pigmented nodular adrenocortical disease |
| Q28082393 | Colorectal cancer risk in hamartomatous polyposis syndromes |
| Q35571401 | Complications in pediatric surgical oncology |
| Q59806431 | Concurrent Hairy Cell Leukemia and Metastatic Merkel Cell Carcinoma |
| Q36456939 | Cowden syndrome: report of a case with immunohistochemical analysis and review of the literature. |
| Q36089372 | Embryonic reversions and lineage infidelities in tumour cells: genome-based models and role of genetic instability |
| Q22122022 | Genetic predisposition to cancer — insights from population genetics |
| Q33614720 | Human adult stem cells as the target cells for the initiation of carcinogenesis and for the generation of "cancer stem cells". |
| Q33834457 | Inference of cancer-specific gene regulatory networks using soft computing rules |
| Q35851661 | Inherited forms of renal cell carcinoma |
| Q38089260 | Molecular diagnosis of primary hyperparathyroidism in familial cancer syndromes |
| Q37316299 | Molecular genetics analysis of hereditary breast and ovarian cancer patients in India |
| Q86615686 | Neonatal tumours |
| Q36961236 | Nested Patch PCR enables highly multiplexed mutation discovery in candidate genes |
| Q24793049 | On the emergence of multifocal cancers |
| Q89458187 | Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation Status |
| Q35749402 | Risk of second primary cancer in men with breast cancer |
| Q81266720 | The early diagnosis of multiple endocrine neoplasia type 1 (MEN 1): a case report |
| Q42469941 | Timing and extent of surgery in patients with familial medullary thyroid carcinoma/multiple endocrine neoplasia 2A-related RET mutations not affecting codon 634. |
| Q35082966 | Zebrafish genomic instability mutants and cancer susceptibility. |
Search more.